Weekly science reads: senescence, alt CRISPR, sickle cell update
Is 2022 going to be any better than 2020 or 2021 when it comes to things in general or for biomedical science? Related to the pandemic? It’s too soon to say but if I had to guess right now I’d venture an optimistic view that overall it’s going to be somewhat better by the end […]
Weekly science reads: senescence, alt CRISPR, sickle cell update Read More »